Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07686484
EARLY_PHASE1

A Trial of HRS-3095 in Healthy Volunteers

Sponsor: Atridia Pty Ltd.

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants

Official title: A Phase 1, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of HRS-3095 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2026-07-30

Completion Date

2026-10-15

Last Updated

2026-07-07

Healthy Volunteers

Yes

Interventions

DRUG

HRS-3095

Single dose HRS-3095 /placebo given orally - Dose level 1

DRUG

HRS-3095

Single dose HRS-3095 /placebo given orally - Dose level 2

DRUG

HRS-3095

Single dose HRS-3095 /placebo given orally - Dose level 3

Locations (1)

Veritus Research

Bayswater, Victoria, Australia